178 related articles for article (PubMed ID: 15488151)
1. Autoimmune inflammatory disorders, systemic corticosteroids and pneumocystis pneumonia: a strategy for prevention.
Sowden E; Carmichael AJ
BMC Infect Dis; 2004 Oct; 4():42. PubMed ID: 15488151
[TBL] [Abstract][Full Text] [Related]
2. Role of primary prophylaxis for pneumocystis pneumonia in patients treated with systemic corticosteroids or other immunosuppressive agents for immune-mediated dermatologic conditions.
Lehman JS; Kalaaji AN
J Am Acad Dermatol; 2010 Nov; 63(5):815-23. PubMed ID: 20643496
[TBL] [Abstract][Full Text] [Related]
3. Pneumocystis carinii pneumonia in patients with connective tissue disease.
Li J; Huang XM; Fang WG; Zeng XJ
J Clin Rheumatol; 2006 Jun; 12(3):114-7. PubMed ID: 16755237
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of Pneumocystis carinii pneumonia in patients with Wegener's granulomatosis.
Jarrousse B; Guillevin L; Bindi P; Hachulla E; Leclerc P; Gilson B; Rémy P; Rossert J; Jacquot C; Nilson B [corrected to Gilson B]
Clin Exp Rheumatol; 1993; 11(6):615-21. PubMed ID: 8299252
[TBL] [Abstract][Full Text] [Related]
5. Pneumocystis jirovecii pneumonia prophylaxis in immunocompromised patients with systemic autoimmune diseases.
Braga BP; Prieto-González S; Hernández-Rodríguez J
Med Clin (Barc); 2019 Jun; 152(12):502-507. PubMed ID: 30853123
[TBL] [Abstract][Full Text] [Related]
6. [Pneumocystis pneumonia among patients with systemic diseases].
Khellaf M; Godeau B
Presse Med; 2009 Feb; 38(2):251-9. PubMed ID: 19062243
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for prophylaxis of Pneumocystis pneumonia cannot rely solely on CD4-cell count in autoimmune and inflammatory diseases.
Baulier G; Issa N; Gabriel F; Accoceberry I; Camou F; Duffau P
Clin Exp Rheumatol; 2018; 36(3):490-493. PubMed ID: 29533748
[TBL] [Abstract][Full Text] [Related]
8. Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases.
Godeau B; Coutant-Perronne V; Le Thi Huong D; Guillevin L; Magadur G; De Bandt M; Dellion S; Rossert J; Rostoker G; Piette JC
J Rheumatol; 1994 Feb; 21(2):246-51. PubMed ID: 8182632
[TBL] [Abstract][Full Text] [Related]
9. Primary brain tumors treated with steroids and radiotherapy: low CD4 counts and risk of infection.
Hughes MA; Parisi M; Grossman S; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1423-6. PubMed ID: 16029802
[TBL] [Abstract][Full Text] [Related]
10. Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients.
Roblot F; Godet C; Le Moal G; Garo B; Faouzi Souala M; Dary M; De Gentile L; Gandji JA; Guimard Y; Lacroix C; Roblot P; Becq-Giraudon B
Eur J Clin Microbiol Infect Dis; 2002 Jul; 21(7):523-31. PubMed ID: 12172743
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
Wordell CJ; Hauptman SP
Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
[TBL] [Abstract][Full Text] [Related]
12. Pneumocystis pneumonia in patients with inflammatory or autoimmune diseases: Usefulness of lymphocyte subtyping.
Li Y; Ghannoum M; Deng C; Gao Y; Zhu H; Yu X; Lavergne V
Int J Infect Dis; 2017 Apr; 57():108-115. PubMed ID: 28223177
[TBL] [Abstract][Full Text] [Related]
13. Pneumocystis pneumonia in patients with immunobullous dermatoses.
Li F; Jin HZ; Su F; Jia L; Sun QN
Int J Dermatol; 2011 Sep; 50(9):1144-9. PubMed ID: 22126881
[TBL] [Abstract][Full Text] [Related]
14. Pneumocystis carinii pneumonia in patients without HIV infection.
Saksasithon S; Sungkanuparph S; Thanakitcharu S
J Med Assoc Thai; 2003 Jul; 86(7):612-6. PubMed ID: 12948254
[TBL] [Abstract][Full Text] [Related]
15. Development of Pneumocystis carinii pneumonia in patients with immunobullous and connective tissue disease receiving immunosuppressive medications.
Gerhart JL; Kalaaji AN
J Am Acad Dermatol; 2010 Jun; 62(6):957-61. PubMed ID: 19828210
[TBL] [Abstract][Full Text] [Related]
16. Benefit of primary prophylaxis before 18 months of age in reducing the incidence of Pneumocystis carinii pneumonia and early death in a cohort of 112 human immunodeficiency virus-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group.
Thea DM; Lambert G; Weedon J; Matheson PB; Abrams EJ; Bamji M; Straus WL; Thomas PA; Krasinski K; Heagarty M
Pediatrics; 1996 Jan; 97(1):59-64. PubMed ID: 8545225
[TBL] [Abstract][Full Text] [Related]
17. Determining the Incidence of Pneumocystis Pneumonia in Patients With Autoimmune Blistering Diseases Not Receiving Routine Prophylaxis.
Amber KT; Lamberts A; Solimani F; Agnoletti AF; Didona D; Euverman I; Cozzani E; Yueh LH; Di Zenzo G; Leshem YA; Mimouni D; Hertl M; Horvath B
JAMA Dermatol; 2017 Nov; 153(11):1137-1141. PubMed ID: 28854309
[TBL] [Abstract][Full Text] [Related]
18. Management of Pneumocystis pneumonia in patients with inflammatory disorders.
Roblot F
Expert Rev Anti Infect Ther; 2005 Jun; 3(3):435-44. PubMed ID: 15954859
[TBL] [Abstract][Full Text] [Related]
19. Pneumocystis pneumonia in HIV-negative adults: missed opportunities for prevention.
Young N; McBride S; Morpeth S; Bryce A; Siddiqui A; Bhally H
N Z Med J; 2020 Aug; 133(1520):27-34. PubMed ID: 32994591
[TBL] [Abstract][Full Text] [Related]
20. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
